Dosage Forms – Page 5

Ono Pharmaceutical Strengthens Oncology Portfolio with Acquisition of Deciphera Pharmaceuticals for $2.4 Billion

1 year ago talkbio0Tagged Acquisition (action), cancer treatments, Clinical Development, Collaboration, Deciphera, Dosage Forms, expansion, Generalized, Market, Oncology Pipeline, strategic

Ono Pharmaceutical, Deciphera Pharmaceuticals, oncology pipeline, acquisition, $2.4 billion, cancer treatments, kinase inhibitors, strategic expansion, global market, clinical development, collaboration.

Endo’s Par Pharmaceutical Recalls Blood Pressure Medication Due to Potential Contamination

1 year ago talkbio0Tagged adulteration, blood pressure medication, Dosage Forms, Endometriosis, Expiration, function, hydrochlorothiazide, Mental Recall, mg/12.5, Tablet Dosage Form

Endo, Par Pharmaceutical, recall, blood pressure medication, contamination, quinapril HCl/ hydrochlorothiazide tablets, USP 20 mg/12.5 mg, lot number 0KG190092, expiration date 03/2022

Incyte Invests in Mast Cell Inhibitors with $750M Escient Acquisition

1 year ago talkbio0Tagged Acquisition (action), Dosage Forms, Drug Development, Escient, Fibrosis, Incyte, Inflammatory disorder, mast cell inhibitors

Incyte, Escient, mast cell inhibitors, acquisition, pharmaceutical, drug development, inflammatory diseases, cancer, fibrosis, $750 million